What Is Halo Nevus? Definition and Terminology
Halo nevus — also known as Sutton's nevus or perinaeval vitiligo — is characterised by a symmetric, well-defined white ring surrounding a melanocytic mole (nevus). This white area forms as a result of the immunological destruction of pigment-producing cells (melanocytes).
Described in 1971 by dermatologist Richard Sutton, after whom it is named, this condition is also known in everyday language as a "ringed mole" or "mole with a white halo."
Mechanism of Formation: The Role of the Immune System
The underlying mechanism of halo nevus is the immune system recognising melanocytes in the nevus as foreign cells and attacking them. The detailed steps are as follows:
- Antigen presentation: Melanocytes in the nevus carry antigens on their surface that the immune system identifies as a potential threat.
- T lymphocyte activation: Cytotoxic CD8+ T lymphocytes and helper CD4+ T lymphocytes become activated and infiltrate the nevus.
- Melanocyte destruction: T lymphocytes attack melanocytes both within the nevus and in the surrounding normal skin, driving them to apoptosis.
- Depigmentation: Melanocyte loss creates a ring-shaped white zone.
- Nevus regression: The central mole gradually fades (becomes a regressing nevus) and may disappear entirely.
This process is considered a benign immune response and generally resolves spontaneously.
Epidemiology: Who Is Affected and When?
Halo nevus occurs in approximately 1% of the general population. Epidemiological characteristics include:
- Most common age group: 10–30 years; particularly adolescents and young adults.
- Sex: Equally common in males and females.
- Location: Most frequently the back; can also occur on the face and extremities.
- Number: Single or multiple lesions may be present.
- Association with vitiligo: Vitiligo is detected in 5–20% of patients with halo nevus, supporting a shared autoimmune mechanism.
- Family history: Familial cases have been reported, but Mendelian inheritance has not been established.
Distinguishing from Melanoma: ABCDE Criteria and Comparison
Distinguishing halo nevus from melanoma is vitally important. A typical halo nevus is not a melanoma; however, some melanomas can also develop a halo. Clinical assessment and dermoscopy are therefore essential:
| Criterion | Typical Halo Nevus (Benign) | Concerning Lesion (Melanoma suspicion) |
|---|---|---|
| A — Asymmetry | Symmetric centre + symmetric halo | Asymmetric lesion or asymmetric halo |
| B — Border | Centre: regular; halo: regular, sharp | Irregular, notched border; asymmetric halo |
| C — Colour | Uniform brown centre; white halo | Multi-coloured centre (black, blue, red) |
| D — Diameter | Centre usually <6 mm, stable | Growing or >6 mm |
| E — Evolution | Slow regression — fades over years | Rapid change, bleeding, crusting |
| Age | Young adult, adolescent | Middle age and above, especially with risk factors |
Warning Signs
If any of the following findings develop in a patient diagnosed with halo nevus, dermatological evaluation should be sought promptly:
- The colour of the central mole is changing or becoming multi-coloured
- The size of the central mole is increasing
- Border irregularity is appearing or worsening
- Itching, bleeding, or ulceration begins
- The halo becomes asymmetric or irregular in shape
- A new halo nevus developing after age 40
- Personal or family history of melanoma
Dermoscopy Findings
Dermoscopic evaluation of halo nevus is the gold standard for distinguishing benign from malignant lesions. At Virtuana Clinic, dermoscopy is used in every pigmented lesion assessment. Typical halo nevus dermoscopy findings include:
- Centre: Regular reticular (network) or globular pattern; homogeneous colour.
- Halo: Peripheral depigmentation — due to absence of melanocytes.
- Regressive change: As the centre fades, colour disappears and grey-white areas become visible.
- Absent findings: Atypical network, blue-black structures, irregular vascular pattern.
Biopsy Indications
Biopsy is not required for halo nevus with typical clinical and dermoscopic appearance. However, biopsy is indicated in the following situations:
- Any abnormality in the ABCDE criteria
- Atypical findings on dermoscopy
- New lesion developing after age 40
- New halo developing in a patient with a history of melanoma
- Any situation in which the clinician is uncertain of the diagnosis
The decision to perform a biopsy must always be made by the clinician. The interpretation "looks benign" must be based on a clinician's examination — not on social media images or self-assessment.
Need for Treatment: Is Spontaneous Regression Possible?
The natural course of halo nevus is generally spontaneous resolution (spontaneous regression). The process occurs in several stages:
- Stage 1: A white halo forms around the normal nevus.
- Stage 2: The central mole begins to fade (becomes lighter in colour).
- Stage 3: The central mole disappears entirely; only the depigmented halo remains.
- Stage 4: The halo also regains normal skin colour; the lesion disappears completely.
This process varies from months to years. For most halo nevi, treatment is not required. The primary approach is monitoring and sun protection.
The Importance of Sun Protection
The depigmented area around the halo contains no melanin and is therefore extremely sensitive to UV damage. This area:
- Is far more susceptible to sunburn than normally pigmented skin.
- UV damage may theoretically contribute to accelerated melanocyte loss or spread to the surrounding area.
- Capillary damage in the depigmented zone may occur more readily with UV exposure.
For this reason, patients diagnosed with halo nevus are advised to use broad-spectrum SPF 50 sunscreen daily and to avoid peak UV hours. This approach also aligns with vitiligo management if concomitant vitiligo is present.
Follow-Up Protocol
The recommended monitoring protocol for patients diagnosed with halo nevus at Virtuana Clinic:
| Timeframe / Situation | Recommended Action |
|---|---|
| Initial Assessment | Dermoscopy + photographic documentation |
| Every 6–12 months | Dermoscopic comparison; accelerated follow-up if changes observed |
| Annually | General screening of all moles |
| Upon new symptom onset | Urgent dermatology evaluation |
| Sun protection | Daily SPF 50 use; avoid peak UV hours |
Halo Nevus and Vitiligo: What Is the Connection?
The relationship between halo nevus and vitiligo is of interest both clinically and mechanistically:
- In both conditions, melanocytes are targeted by the immune system.
- Vitiligo is detected in 5–20% of patients with halo nevus.
- Halo nevus is more common in patients with vitiligo.
- Some patients with halo nevus may later develop vitiligo.
- However, halo nevus is definitely not vitiligo, and it does not guarantee that vitiligo will develop.
In patients diagnosed with halo nevus, screening for the presence of vitiligo and investigation if necessary is recommended.
Halo Nevus Assessment at Virtuana Clinic
For patients in Kocaeli / Izmit who notice a white halo forming around a mole, Virtuana Clinic provides dermoscopy-assisted diagnosis, photographic documentation, and an individualised monitoring protocol. Determining whether a lesion is benign or malignant is only possible through specialist dermatological examination.
If you suspect halo nevus or have noticed a change in a lesion, you are welcome to visit Virtuana Clinic. Please contact us for appointment and pricing details.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.